Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of his study is to evaluate the efficacy and safety of Sorafenib versus placebo in subjects with locally advanced medullary thyroid cancer (MTC). The primary study objective is to compare the Progression-free Survival (PFS) of the Sorafenib treatment group with the placebo treatment group in patients with advanced MTC.
Epistemonikos ID: 2cf25b0cd9abf177f7d96948d74be714cfeb0043
First added on: May 11, 2024